Drug Shortage Report for AA-IPRAVENT
| Report ID | 152767 |
| Drug Identification Number | 02126222 |
| Brand name | APO-IPRAVENT SOLUTION - INH 250MCG/ML |
| Common or Proper name | IPRAVENT |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 250MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20 ML |
| ATC code | R03BB |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-10 |
| Estimated end date | 2022-04-01 |
| Actual end date | 2022-03-25 |
| Shortage status | Resolved |
| Updated date | 2022-03-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-03-28 | French | Compare |
| v5 | 2022-03-28 | English | Compare |
| v4 | 2022-02-24 | French | Compare |
| v3 | 2022-02-24 | English | Compare |
| v2 | 2022-01-14 | French | Compare |
| v1 | 2022-01-14 | English | Compare |
Showing 1 to 6 of 6